Cell Avidity: Understanding the mechanism of action through cell-cell binding

While conventional assays such as affinity, cytokine secretion, and cytotoxicity provide valuable data at a molecular level, this information can be insufficient to fully characterize and select the best immunotherapies. There is still a lack of understanding about direct cell-cell interactions that drive functional processes.

Cell Avidity, the collective strength of interactions between an effector and its target, is critical to understanding the mechanism of action for therapeutic candidates. This technology enables researchers to assess cell binding characteristics to interrogate potency, safety, sensitivity, binding kinetics, and more.

Join this live webinar  for an overview of the technology and recent publications highlighting how researchers have used Cell Avidity to thoroughly characterize cell-cell binding.